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ATP-induced ventricular asystole and hypotension during endovascular stenting surgery
Purpose: To describe four cases of endoluminal stenting surgery in which adenosine 5'-triphosphate (ATP) was used to arrest the heart for accurate placement of the stent-graft.
Clinical features: Four patients with descending thoracic aortic aneurysm were anaesthetized for deployment of a self-expanding stent-graft. Maintenance of general anaesthesia was performed with isoflurane and nitrous oxide in three patients, and with fentanyl and propofol in another. An initial trial of 20 mg ATP was administered via a central venous catheter as rapidly as possible, and produced third degree AV block of 8 • 1.7 sec and 59.7 ---17.5 sec hypotension, mean blood pressure < 60 mmHg, in three patients. The time to onset of AV block was 15.7 __: 6.7 sec. In these patients, deployment of the stent-graft was performed during ventricular asystole produced by 30 mg ATP, which produced 16.3 _ 2. I sec third and second degree AV block. In one patient anaesthetized with fentanyl and propofol, 20 mg ATP did not change AV conduction. However, after I 0 mg edrophonium, 20 mg ATP produced 9 sec third degree AV block. In all cases, heart rate and PQ interval were restored to the pre-drug control level within 50 sec after the commencement of AV block. There were no clinical complications related to this procedure in any patient.
Conclusion: ATP is a convenient and suitable agent to produce transient ventricular asystole for the precise deployment of a self-expanding stent-graft. Co-administration of a parasympathomimetic agent might potentiate the inhibitory effect of ATP on AV conduction.
Objectif : D&rire quatre cas de chirurgie par proth&e endoluminale pendant lesquelles I'adEnosine 5~-triphosphate (ATP) a ~tE utilisEe pour arr&er le coeur et permettre un positionnement precis du systEme greffe-tuteur. 
E
NDOVASCULAR stent-graft repair of a descending thoracic aortic aneurysm is a newly developed alternative procedure to conventional repair with graft interposition via thoracotomy. 1 As the stent-graft is deployed, transient cardiac asystole for about 20 sec and/or a transient decrease in mean arterial pressure (MAP) to < 50 mmHg are required for accurate placement of the stent-graft, x;
We report four cases of descending thoracic aortic aneurysm in which adenosine 5'-triphosphate (ATP) was used to produce cardiac asystole.
Case reports
Demographic data and anaesthetic methods are shown in Table I . After insertion of an intracardiac pacing catheter, a trial dose of ATP was administered via a central venous catheter. In patients #3 and #4, the ventricular regional wall motion and intraventricular volume were assessed by transoesophageal echocardiography (TEE). In all cases, deployment of the stent-graft was performed within 10 sec.
Cardiovascular effects of ATP
Patient #1 ATP, 20 mg, was administered rapidly via a central venous catheter. Unexpectedly, it only decreased MAP moderately without reducing heart rate. Thus, 10 mg edrophonium was injected to potentiate the negative dromotropic effect of ATP. Edrophonium decreased heart rate from 73 to 55 bpm, while MAP increased slightly. Subsequent administration of 20 mg ATP produced ventricular asystole of 9 sec from third degree atrioventricular (AV) block (AV block with 22 consecutive blocked P waves). Onset of AV block, blood pressure recovery (time from commencement of third degree AV block to recovery of MAP > 60 mmHg), and ECG CANADIAN JOURNAL OF ANAESTHESIA recovery (time from commencement of third degree AV block to the recovery of ECG parameters such as sinus cycle length and PQ interval to the predrug control level) are summarized in Table II . The onset time was 16 sec and the blood pressure recovery time was 31 sec. Fifty mg ATP and 10 mg edrophonium were injected for the deployment of the stent-graft.
Patients #2, 3, 4 In these patients, 20 mg ATP was administered for a trial, then the stent-grafts were deployed during ventricular asystole produced by 30 mg ATE The haemodynamic variables and ECG parameters are shown in Table II . Twenty mg and 30 mg ATP produced AV block (second and third degree) for 8 and 16.3 sec, respectively. Time to onset of AV block was about 15 sec. Blood pressure recovery time was 60 sec for 20 mg ATP and 74 sec for 30 mg ATP. In patients #3 and 4, cardiac performance was assessed by TEE. The ventricles were brought to a standstill at a diastolic position after the administration of ATP, and did not distend during asystole. Abnormal ventricular regional wall motion was not recognized after the resumption of the beating.
Discussion
Rapid bolus injection of ATP via the central venous catheter produced abrupt cessation of AV conduction, resulting in ventricular asystole. The time to onset of AV block was about 15 sec. The sinus cycle length and PQ interval were restored promptly to the predrug control level, while hypotension was still present after recovery of the ECG parameters.
ATP is thought to be converted to adenosine immediately after administration, and act on the adenosine receptors, s,4 The present results are very similar to the The cardiovascular effects of adenosine disappear quickly because of its erythrocyte and endothelial cell uptake, and subsequent deamination to inosine or phosphorylation to adenosine monophosphate. 7 The half-life of adenosine in undiluted human blood is about 9.3 sec. s The difference between ATP and adenosine is the need to administer about 1.5 times larger dose of the parent compound. 7
The dose of ATP required to produce adequate duration of the ventricular asystole is unpredictable. In our first case, 20 mg ATP produced only a slight decrease in arterial pressure, whereas in the other cases the same amount of ATP produced third degree AV block and moderate hypotension. Baker et al. administered 12, 27, 45 mg adenosine to produce cardiac asystole of 20-30 sec in three patients, s Inasmuch as it is impossible to redo the deployment of the selfexpanding stent-graft once it expands, it is necessary to test the cardiovascular effects of ATP prior to expanding the stent in each case. It is recommended to start with 15-20 mg ATP. According to our experience, ventricular asystole of 10 sec seems to be sufficient to deploy the self-expanding stent-graft.
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Although it is unclear why patient #1 was resistant to ATP, moderate activation of parasympathetic tone might be useful for potentiation of the negative dromotropic effect of ATP in such a case. Muscarinic acetylcholine M 2 receptors and adenosine A L receptors share, some if not all, the intracellular mechanism underlying the negative dromotropic response of the AV node? Therefore, proper activation of muscarinic receptors could make the AV node sensitive to the negative dromotropic effect of ATP/adenosine. Interestingly, the combination of 10 mg edrophonium and 20 mg ATP in the first case and 20 mg ATP alone in the other three cases produced similar degrees of AV block and exhibited similar ECG recovery time, whereas the duration of hypotension seemed to be shorter in the first case than in the others (Table 11 ). The result suggests that edrophonium might selectively potentiate the negative dromotropic effect of ATP without affecting the vasodilatory effect of the agent.
The safety ofATP-produced ventricular asystole has not been verified. Mattle et aL reported that cerebral circulatory arrest of 10 sec could cause loss of consciousness. 1~ Therefore, ventricular asystole and the following hypotension produced by ATP could cause not only cardiac, but also neurological complications, although ATP did not produce any deleterious effects on the ventricular performance confirmed by TEE in patients #3 and 4. In conclusion, ATP is very convenient agent that stops and/or reduces aortic flow for accurate placement of a stent-graft. Edrophonium may potentiate the negative dromotropic effect of ATP selectively without potentiating the vasodilatory effect of the agent.
